Aescap et al. in €30m Biocartis round

Biovest, Advent Venture Partners, several Biocartis employees and Benaruca, the family investment vehicle of Biocartis' co-founder Rudi Pauwels, also participated in the round.

Biocartis SA is a biotech company active in the field of personalized medicine and is focused on molecular diagnostics based on its proprietary micro-technology and sample preparation platforms. The company was founded in 2007 and is based at the EPFL Science Park in Lausanne, Switzerland and at the High Tech Campus in Eindhoven, The Netherlands.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Early-stage
• Healthcare
• Switzerland